Trademarkia Logo

Australia

AU$
RDEXA
Cancelled: Cancelled at the request of IB

Last updated on 12 May 2016

Owner Info

Portola Pharmaceuticals, Inc.

270 East Grand Avenue

South San Francisco CA 94080, UNITED STATES OF AMERICA

Serial Number

1705861 filed on 27 May 2015

Correspondent

Harold Milstein Sheppard Mullin Richter & Hampton LLP

379 Lytton Avenue,

Palo Alto CA 94301,

UNITED STATES OF AMERICA

RDEXA

Classification Information


Class [005]
Pharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the treatment of coagulation disorders, thrombosis, he Read More

Mark Details


Serial Number

1705861

Registered On

27 May 2015

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

14 May 2015

Mark Type

US

Legal History


Show more

Status DateAction Taken
12th May 2016Cancellation of Entry in Register Published
5th May 2016Cancel IP Right
28th Apr 2016Cancellation of Registration
24th Dec 2015IP Right Registration Published
16th Dec 2015Register Trade Mark
16th Dec 2015Application Status
8th Oct 2015IP Right Acceptance Published
29th Sept 2015Amend Status from Awaiting Advertisement
29th Jul 2015User Created Notice correspondence sent
29th Jul 2015Clear Examination report approved